Industry
UK Medical Cannabis Patient Numbers Set to Reach 140,000 in 2026, Industry Report Finds
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
For Professionals
Prescribing, clinical practice and regulatory change for the clinicians building this field.
Latest in For Professionals
Industry
Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Medical cannabis
The Power of Patient Stories: How Lived Experience is Shifting Medical Cannabis Stigma
Despite medical cannabis being legal in the UK for almost eight years, many patients remain hesitant or unsure about whether it is right for them. While awareness of the legality […]
Industry
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
Industry
Prescribing, Products and Patient Access: What to Expect from Medical Cannabis in 2026
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
Industry
What Is Really Going on in the UK’s Medical Cannabis Market?
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
Industry
113 Botanicals Launches £2m Raise to Bring Controlled-Release Cannabis Capsule to UK Patients
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Industry
Why CPD-Certification Matters for Medical Cannabis Clinicians
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
Industry
Experts Publish New Guidelines for Best Practice in Prescribing Cannabis-Based Medicines
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
Industry
Rizzle Kicks Star Partners with Medical Cannabis Clinic to Raise Awareness of Men’s Mental Health
Jordan Stephens aims to shed light on the role of alternative treatments in supporting mental wellbeing.
Industry
Curaleaf Partners with Medical Cannabis Clinicians Society to Strengthen UK Prescriber Education
The Medical Cannabis Clinicians Society (MCCS) and Curaleaf Laboratories have formed a new partnership aimed at addressing critical knowledge gaps.
Industry
Thousands of CBD Products Enter Final Stage of UK Novel Foods Approval
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
Medical cannabis
Curaleaf Laboratories launches first certified liquid medical cannabis inhaler for UK patients
Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, […]